CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis

Clinical trial NCT06785519 · RECRUITING

Trial details

NCT number: NCT06785519
Sponsor: He Huang
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2025-01-31
Primary completion: 2027-10-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.